Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Rubella
2021
2010
Americas
Clear all
Type of publications
NITAG documentation
(66)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(69)
Africa
(17)
Europe
(83)
South-East Asia
(2)
Western Pacific
(17)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(18)
Chile
(9)
United States of America
(39)
Diseases
COVID-19
(64)
Pneumococcal disease
(4)
Rubella
(1)
Ebola
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(6)
Influenza
(4)
Japanese encephalitis
(1)
Measles
(2)
Meningococcal disease
(2)
Mumps
(1)
Rabies
(1)
Rotavirus
(4)
Varicella
(3)
Yellow fever
(2)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Target population
Adults
(2)
All age groups
(2)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2021
(64)
2010
(5)
2024
(3)
2023
(14)
2022
(45)
2020
(63)
2019
(4)
2018
(8)
2017
(1)
2016
(1)
2015
(1)
2014
(3)
2013
(3)
2012
(2)
2008
(2)
2004
(2)
2003
(3)
2002
(2)
2001
(1)
1997
(1)
69 results found
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2010
∙
NACI
NACI Statement on measles-mumps-rubella-varicella vaccine - September 2010
2010
∙
Allison McGeer
NACI Update on Pediatric Invasive Pneumococcal Disease and Recommended Use of Conjugate Pneumococcal Vaccines - June 2010
2010
∙
ACIP
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children
2010
∙
ACIP
Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
2010
∙
ACIP
Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register